PT1756142E - Pseudopéptidos secretagogos da hormona de crescimento - Google Patents
Pseudopéptidos secretagogos da hormona de crescimento Download PDFInfo
- Publication number
- PT1756142E PT1756142E PT05741341T PT05741341T PT1756142E PT 1756142 E PT1756142 E PT 1756142E PT 05741341 T PT05741341 T PT 05741341T PT 05741341 T PT05741341 T PT 05741341T PT 1756142 E PT1756142 E PT 1756142E
- Authority
- PT
- Portugal
- Prior art keywords
- growth hormone
- pseudopeptides
- release
- growth
- hormone secretagogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/835,563 US7034050B2 (en) | 2004-04-28 | 2004-04-28 | Pseudopeptides growth hormone secretagogues |
US64279305P | 2005-01-11 | 2005-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1756142E true PT1756142E (pt) | 2008-09-29 |
Family
ID=34967415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT05741341T PT1756142E (pt) | 2004-04-28 | 2005-04-21 | Pseudopéptidos secretagogos da hormona de crescimento |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1756142B1 (pt) |
JP (1) | JP2008501641A (pt) |
AT (1) | ATE399791T1 (pt) |
CA (1) | CA2564613A1 (pt) |
CY (1) | CY1108304T1 (pt) |
DE (1) | DE602005007895D1 (pt) |
ES (1) | ES2309756T3 (pt) |
HK (1) | HK1102373A1 (pt) |
PL (1) | PL1756142T3 (pt) |
PT (1) | PT1756142E (pt) |
WO (1) | WO2005105828A1 (pt) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1277113B1 (it) * | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
-
2005
- 2005-04-21 WO PCT/EP2005/004273 patent/WO2005105828A1/en active IP Right Grant
- 2005-04-21 CA CA002564613A patent/CA2564613A1/en not_active Abandoned
- 2005-04-21 AT AT05741341T patent/ATE399791T1/de active
- 2005-04-21 PT PT05741341T patent/PT1756142E/pt unknown
- 2005-04-21 ES ES05741341T patent/ES2309756T3/es active Active
- 2005-04-21 PL PL05741341T patent/PL1756142T3/pl unknown
- 2005-04-21 JP JP2007509934A patent/JP2008501641A/ja active Pending
- 2005-04-21 EP EP05741341A patent/EP1756142B1/en not_active Not-in-force
- 2005-04-21 DE DE602005007895T patent/DE602005007895D1/de active Active
-
2007
- 2007-08-27 HK HK07109314A patent/HK1102373A1/xx not_active IP Right Cessation
-
2008
- 2008-09-02 CY CY20081100930T patent/CY1108304T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008501641A (ja) | 2008-01-24 |
ES2309756T3 (es) | 2008-12-16 |
EP1756142A1 (en) | 2007-02-28 |
PL1756142T3 (pl) | 2008-12-31 |
ATE399791T1 (de) | 2008-07-15 |
CA2564613A1 (en) | 2005-11-10 |
DE602005007895D1 (de) | 2008-08-14 |
WO2005105828A1 (en) | 2005-11-10 |
HK1102373A1 (en) | 2007-11-16 |
CY1108304T1 (el) | 2014-02-12 |
EP1756142B1 (en) | 2008-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03007837A (es) | Composiciones para suministrar bisfosfonatos. | |
NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
ATE365045T1 (de) | Vermehrung des weich- sowie des knochengewebes anhand von aus muskeln stammenden vorläuferzellen,sowie damit verbundene zusammensetzungen und behandlungsformen | |
IL188475A0 (en) | Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors | |
MY134190A (en) | Compositions and methods for stimulating gastrointestinal motility. | |
AR078304A1 (es) | Agonistas receptores de oxitocina | |
WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
MX2010004682A (es) | Metodo de supresion de hormonas en humanos. | |
WO2007014258A3 (en) | Growth hormone secretagogues | |
AU2003248888A1 (en) | Peptide composition for treatment of sexual dysfunction | |
WO2009052489A3 (en) | Novel inhibitors of mammalian tight junction opening | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
TW200637561A (en) | Antitumor agent | |
ATE537249T1 (de) | Wiedergewinnung von gewebefunktion nach verabreichung von b-zellen an verletztes gewebe | |
MXPA04011835A (es) | Tratamiento de combinacion para la depresion y ansiedad. | |
TW200612962A (en) | Estriol and estetrol prodrugs | |
MX2007005525A (es) | Tratamiento terapeutico de resorcion ose acelerada. | |
HK1102373A1 (en) | Pseudopeptides growth hormone secretagogues | |
WO2005072766A3 (en) | Peptides that bind to hsp90 proteins | |
DK1339735T3 (da) | Fremgangsmåde til fremstilling af tryptophanrige peptider | |
GB0203419D0 (en) | Peptide | |
AU2003245781A1 (en) | Mhc class ii peptide epitope of 5t4 antigen | |
DE60318716D1 (de) | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren | |
Du et al. | Modulation of orphanin FQ or electroacupuncture (EA) on immune function of traumatic rats | |
EP1730174A4 (en) | PEPTIDE CARRIER FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS |